ARCHIVES

Gleevec Improves Survival Of CML In Accelerated Phase

This article is from The Cancer Letter archive.

Vol. 25 No. 12 | December 27, 2002

Download PDF Visit The Full Archive

Related Articles

As Avastin Decision Nears, Patient Groups Split On PFS In Front Line Breast Cancer.

February 22, 2008

Avastin Phase III Trial Meets Endpoint: PFS in Platinum-Sensitive Ovarian Cancer

February 25, 2011

Award Fees Show House NCI thinks FCRF Contractors Are Performing

August 15, 1986

Paulette Gray named director of NCI Division of Extramural Activities.

April 22, 2005

NY Attorney General Sues Drug Companies Over Cancer Drug Pricing Deals

February 14, 2003

Cancer Groups Propose Six Characteristics Of Next FDA Head.

December 19, 2008